GSK, Human Genome Sciences To Co-Develop Antibody For Cancer Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
Human Genome Sciences has completed a Phase II trial of HGS-ETR1 for non-small cell lung cancer, with trials ongoing for non-Hodgkin's lymphoma and colorectal cancer.